PTC Therapeutics, Inc.

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Jul 30, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Jun 18, 2026 8-K Other events Jun 16, 2026 8-K Director or officer change Jun 9, 2026 8-K Shareholder vote results Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2026 8-K Regulation FD disclosure Apr 28, 2026 8-K Director or officer change; Regulation FD disclosure Mar 25, 2026 10-K Fiscal year ended 2025-12-31 Feb 19, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 19, 2026 8-K Regulation FD disclosure Feb 12, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Entered a material agreement Dec 29, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2025 8-K Regulation FD disclosure Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Entered a material agreement Aug 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 8-K Regulation FD disclosure Jul 28, 2025 8-K Shareholder vote results Jun 17, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2025 8-K Regulation FD disclosure May 5, 2025 8-K Regulation FD disclosure Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jan 3, 2025 8-K Entered a material agreement; Regulation FD disclosure Dec 2, 2024 8-K Entered a material agreement; Regulation FD disclosure Nov 27, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 7, 2024 8-K Regulation FD disclosure Oct 18, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 8-K Regulation FD disclosure Jun 28, 2024 8-K Entered a material agreement; Shareholder vote results; Regulation FD disclosure Jun 20, 2024